Business Description
NeoGenomics Inc
NAICS : 541714
SIC : 8734
ISIN : US64049M2098
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.63 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | -47.6 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.02 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year FCF Growth Rate | 0.3 | |||||
3-Year Book Growth Rate | 6.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.24 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.79 | |||||
9-Day RSI | 59.17 | |||||
14-Day RSI | 56.69 | |||||
6-1 Month Momentum % | -4.76 | |||||
12-1 Month Momentum % | -15.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.48 | |||||
Quick Ratio | 7.22 | |||||
Cash Ratio | 5.02 | |||||
Days Inventory | 24.22 | |||||
Days Sales Outstanding | 77.51 | |||||
Days Payable | 19.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -0.08 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.8 | |||||
Operating Margin % | -15.46 | |||||
Net Margin % | -13.79 | |||||
FCF Margin % | -6.49 | |||||
ROE % | -8.88 | |||||
ROA % | -5.01 | |||||
ROIC % | -7.06 | |||||
ROC (Joel Greenblatt) % | -30.44 | |||||
ROCE % | -5.39 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.25 | |||||
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 55.92 | |||||
EV-to-EBIT | -26.08 | |||||
EV-to-EBITDA | -175.1 | |||||
EV-to-Revenue | 3.66 | |||||
EV-to-Forward-Revenue | 2.49 | |||||
EV-to-FCF | -56.52 | |||||
Price-to-Projected-FCF | 5.78 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
Earnings Yield (Greenblatt) % | -3.83 | |||||
FCF Yield % | -1.97 | |||||
Forward Rate of Return (Yacktman) % | -8.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NeoGenomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 564.367 | ||
EPS (TTM) (€) | -0.61 | ||
Beta | 0.9 | ||
Volatility % | 48.62 | ||
14-Day RSI | 56.69 | ||
14-Day ATR (€) | 0.399689 | ||
20-Day SMA (€) | 13.43 | ||
12-1 Month Momentum % | -15.66 | ||
52-Week Range (€) | 11.1 - 18.6 | ||
Shares Outstanding (Mil) | 127.71 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NeoGenomics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NeoGenomics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
NeoGenomics Inc Frequently Asked Questions
What is NeoGenomics Inc(FRA:NG9)'s stock price today?
When is next earnings date of NeoGenomics Inc(FRA:NG9)?
Does NeoGenomics Inc(FRA:NG9) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |